SCHEMBL8194152

SCHEMBL8194152

CCOc1cccc(C=C2SC(=S)NC2=S)c1O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IGF1R P08069 2/20 0.63
▸ ALDH1A1 P00352 6/20 0.50
▸ MAPT P10636 6/20 0.50
▸ MEN1 O00255 5/20 0.50
▸ KMT2A Q03164 5/20 0.50
▸ TDP1 Q9NUW8 4/20 0.50
▸ GAA P10253 3/20 0.50
▸ MAPK1 P28482 2/20 0.50
▸ RAB9A P51151 2/20 0.50
▸ DYRK1A Q13627 2/20 0.46
▸ PIM1 P11309 1/20 0.46
▸ PIM3 Q86V86 1/20 0.46
▸ DYRK2 Q92630 1/20 0.46
▸ PIM2 Q9P1W9 1/20 0.46
▸ GSK3B P49841 1/20 0.46
▸ PDE4B Q07343 4/20 0.44
▸ NAT1 P18440 2/20 0.44
▸ PDE3A Q14432 3/20 0.44
▸ POLB P06746 3/20 0.43
▸ SMN1; SMN2 Q16637 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8194151 1.00 IGF1R (0.63) IGF1RALDH1A1MAPTMEN1KMT2A
SCHEMBL8187541 0.76 IGF1R (0.78) IGF1RALDH1A1MAPTMEN1KMT2A
SCHEMBL8187544 0.76 IGF1R (0.78) IGF1RALDH1A1MAPTMEN1KMT2A
SCHEMBL8173537 0.75 GSK3B (0.59) ALDH1A1MEN1KMT2ATDP1PIM1
SCHEMBL8173541 0.75 GSK3B (0.59) ALDH1A1MEN1KMT2ATDP1PIM1
SCHEMBL8172009 0.75 PDE4B (0.46) IGF1RALDH1A1MAPTMEN1KMT2A
SCHEMBL8172007 0.75 PDE4B (0.46) IGF1RALDH1A1MAPTMEN1KMT2A
SCHEMBL8192000 0.74 NAT1 (0.74) ALDH1A1MAPTMEN1KMT2ATDP1
SCHEMBL8192006 0.74 NAT1 (0.74) ALDH1A1MAPTMEN1KMT2ATDP1
SCHEMBL8189590 0.73 TDP1 (0.70) IGF1RALDH1A1MAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2000018748-A1 RHODANINE DERIVATIVES FOR THE TREATMENT AND PREVENTION OF METABOLIC BONE DISORDERS ROCHE DIAGNOSTICS GMBH (DE) 2000-04-06 — — WO disclosed
Send feedback